Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
Grifols Total Assets (Quarterly): 22.65B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.65B |
| June 30, 2024 | 23.89B |
| December 31, 2023 | 23.70B |
| September 30, 2023 | 23.36B |
| June 30, 2023 | 23.29B |
| December 31, 2022 | 23.09B |
| June 30, 2022 | 21.98B |
| June 30, 2021 | 19.29B |
| March 31, 2021 | 18.92B |
| December 31, 2020 | 18.79B |
| September 30, 2020 | 18.37B |
| June 30, 2020 | 17.54B |
| March 31, 2020 | 17.53B |
| December 31, 2019 | 17.41B |
| September 30, 2019 | 15.36B |
| June 30, 2019 | 15.15B |
| March 31, 2019 | 15.03B |
| December 31, 2018 | 14.27B |
| September 30, 2018 | 13.69B |
| June 30, 2018 | 13.22B |
| March 31, 2018 | 13.41B |
| December 31, 2017 | 13.10B |
| September 30, 2017 | 12.97B |
| June 30, 2017 | 12.72B |
| March 31, 2017 | 12.51B |
| Date | Value |
|---|---|
| December 31, 2016 | 10.71B |
| September 30, 2016 | 10.73B |
| June 30, 2016 | 10.61B |
| March 31, 2016 | 10.47B |
| December 31, 2015 | 10.50B |
| September 30, 2015 | 10.33B |
| June 30, 2015 | 10.20B |
| March 31, 2015 | 10.15B |
| December 31, 2014 | 10.28B |
| September 30, 2014 | 10.28B |
| June 30, 2014 | 9.927B |
| March 31, 2014 | 9.892B |
| December 31, 2013 | 8.066B |
| September 30, 2013 | 7.707B |
| June 30, 2013 | 7.619B |
| March 31, 2013 | 7.412B |
| December 31, 2012 | 7.442B |
| September 30, 2012 | 7.537B |
| June 30, 2012 | 7.355B |
| March 31, 2012 | 7.379B |
| December 31, 2011 | 7.305B |
| September 30, 2011 | 7.452B |
| June 30, 2011 | 7.737B |
| December 31, 2010 | 2.512B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.41B
Minimum
Dec 2019
23.89B
Maximum
Jun 2024
20.70B
Average
20.64B
Median
Total Assets (Quarterly) Benchmarks
| Cellectis SA | 395.88M |
| Adaptimmune Therapeutics PLC | 321.70M |
| Akari Therapeutics PLC | 5.076M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.73B |
| Shareholders Equity (Quarterly) | 5.975B |
| Current Ratio | 2.260 |
| Net Debt Paydown Yield | 31.04% |